Photodynamic therapy for choroidal neovascularization associated with submacular hemorrhage in age-related macular degeneration

Ophthalmic Surgery Lasers and Imaging

Volumn 37, Issue 4, 2006, Pages 278-283

  Bakri, Sophie J ^a   Nickel, Jonathan ^b   Yoganathan, Pradeepa ^b   Beer, Paul M ^b  

^a MAYO CLINIC   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA FOVEA; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA HEMORRHAGE; STATISTICAL ANALYSIS; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33746712947     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20060701-03     Document Type: Article

References (20)

1. Bennett SR, Folk JC, Blodi CF, Klugman M. Factors prognostic of visual outcome in patients with subretinal hemorrhage. Am J Ophthalmol. 1990;109:33-37.
2. Avery R, Fekrat S, Hawkins BS, Bressler NM. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina. 1996;16:183-189.
3. Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica. 1999;213:97-102.
4. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol. 1982;94:762-773.
5. Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol. 1991;109:1242-1257.
6. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP Report 1. Arch Ophthalmol. 1999;117:1329-1345.
7. Bressler NM. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials. TAP Report 2. Arch Ophthalmol. 2001;119:198-207.
8. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. Verteporfin in Photodynamic Therapy Report 2. Am J Ophthalmol. 2001;131:541-560.
9. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol. 1994;118:559-568.
10. Ibanez HE, Williams DF, Thomas MA, et al. Surgical management of submacular hemorrhage: a series of 47 consecutive cases. Arch Ophthalmol. 1995;113:62-69.
11. Lim JI, Drews-Botsch C, Sternberg P Jr, Capone A Jr, Aaberg TM Sr. Submacular hemorrhage removal. Ophthalmology. 1995;102:1393-1399.
12. Moriarty AP, McAllister IL, Constable IJ. Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage. Eye. 1995;9:582-588.
13. Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol. 1996;121:267-275.
14. Ohji M, Saito Y, Hayashi A, Lewis JM, Tano Y. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol. 1998;116:1326-1332.
15. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology. 1999;106:1900-1907.
16. Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC. Submacular recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology. 2004;111:1201-1208.
17. Erratum in: Ophthalmology. 2004;111:1640.
18. Dellaporta AN. Evacuation of submacular hemorrhage. Int Ophthalmol. 1994;18:25-31.
19. Bressler NM, Hawkins BS, Sternberg P Jr, McDonald HR. Are the submacular surgery trials still relevant in an era of photodynamic therapy? Ophthalmology. 2001;108:435-436.
20. Kamei M, Misono K, Lewis H. A study of the ability of tissue plasminogen activator to diffuse into the submacular space after intravitreal injection in rabbits. Am J Ophthalmol. 1999;128:739-746.